Cel Sci Corporation (CVM)

[W_W]

There are two groups of patient:
High risk group, which need to take chemo. They did with or without Multikine within this group, the results are no improvement, consider 0% improvement.
Low risk group, which don't need to take chemo, they also did with or without Multikine within this group, the results are 14% improvement @ 5 years. They will apply for FDA approval for this group.
They didn't give out the group sizes, but P value has some indication.
Within high risk group, they didn't do Multikine + no chemo vs no Multikine +chemo. This comparison will show whether Multikine is possible to replace chemo or not. They may do it later after Multikine is approved by FDA.